In its press release, WADA “considers that the conclusion of absence of fault or negligence was not correct with regard to the applicable rules” and therefore requests a suspension period of one to two years” for the Italian player, without these results since his positive tests, including his victory at the US Open, being canceled.
“As this matter is ongoing before the CAS, WADA will not make any further comments at this stage,” the text specifies.
The Montreal-based agency indicated on September 10 that it had not yet decided whether or not it was going to appeal the non-suspension of the world No.1 in the ATP rankings, the case being “still under review.” study “.
Jannik Sinner suffered two positive doping tests in March 2024 eight days apart: on March 10 during the Indian Wells tournament and on March 18 out of competition, but just before the Miami tournament. Trace amounts of clostebol (anabolic) were found in his urine.
The Italian defended himself by explaining that he had suffered “contamination by a member of his staff, who had applied an over-the-counter spray containing clostebol to his own hand to treat a small injury”, according to the ITIA Agency which accepted his defense and officially cleared him at the end of August.
The player, who won the first Grand Slam tournament of his career in January in Melbourne, lost the ATP points and the winnings of the tournament during which the positive test was recorded.
Three weeks ago, Sinner became the first world No.1 to win at Flushing Meadows among men since Rafael Nadal in 2017, and the first Italian to lift the trophy in New York.
Before the US Open, Sinner had separated from his physiotherapist Giacomo Naldi, believed to have unintentionally contaminated him, and from his physical trainer, Umberto Ferrara, who had provided Naldi with the incriminated spray.
